Woodline Partners’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.6M | Buy |
1,704,800
+79,045
| +5% | +$3.41M | 0.39% | 47 |
|
|
2025
Q1 | $56.2M | Sell |
1,625,755
-585,766
| -26% | -$20.2M | 0.37% | 71 |
|
|
2024
Q4 | $60.7M | Buy |
2,211,521
+1,261,772
| +133% | +$34.6M | 0.41% | 55 |
|
|
2024
Q3 | $24.2M | Buy |
949,749
+179
| +0% | +$4.56K | 0.2% | 166 |
|
|
2024
Q2 | $24.1M | Buy |
949,570
+248,821
| +36% | +$6.3M | 0.23% | 139 |
|
|
2024
Q1 | $21.7M | Buy |
700,749
+410,749
| +142% | +$12.7M | 0.2% | 158 |
|
|
2023
Q4 | $11.7M | Sell |
290,000
-835,634
| -74% | -$33.7M | 0.13% | 211 |
|
|
2023
Q3 | $29.7M | Buy |
1,125,634
+835,634
| +288% | +$22M | 0.35% | 75 |
|
|
2023
Q2 | $4.99M | Sell |
290,000
-23,195
| -7% | -$399K | 0.06% | 288 |
|
|
2023
Q1 | $5.19M | Buy |
313,195
+216,896
| +225% | +$3.6M | 0.07% | 289 |
|
|
2022
Q4 | $734K | Buy |
+96,299
| New | +$734K | 0.01% | 563 |
|